Gardner, MA: New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support the company’s worldwide growth initiatives, including fueling the expansion of peptide synthesis capabilities to better serve an […]
San Diego, Calif. — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.5 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National Institute on Drug Abuse to continue its development of imaging […]
PROVIDENCE RI Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation. Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Mappingâ„¢ whole-genome electronic mapping platform. HD-Mapping has applications in a wide variety of […]
STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNAâ€) (“we,†“us,†“our,†the “Companyâ€), a leader in large-scale PCR-based DNA manufacturing, today announced that the Nasdaq Hearings Panel (the “Panelâ€) , has granted Applied DNA’s request for an extension through December 31, 2019, to comply with all applicable criteria for continued listing of the Company’s […]
SAN DIEGO — Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures. The proceeds of the financing will be used to advance the company’s proprietary enzymatic DNA synthesis technology to power DNA-based products […]
Wädenswil/Zurich, Switzerland – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced that is has raised CHF 8 million in the first closing as part of a Series C financing round. The round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation (NYSE: WAT) as well as existing private investors. Robert […]
Hesperos, Inc., (www.hesperosinc.com) announced today the University of Central Florida (UCF) received the first phase of a $3.8 million milestone-based National Institutes of Health (NIH) grant for research involving the company’s human-on-a-chip system. “We are grateful to have funding to support research in an area that represents such a large and growing need,†said Dr. […]
ASHLAND, Mass. – BioSurfaces, Inc. (BioSurfaces) was awarded a contract from the National Center for Advancing Translational Sciences (NCATS) BioPrinting Lab at the National Institutes of Health to produce 96-well tissue culture plate assemblies that include its proprietary electrospun materials.   The objective is to deliver prototype 96-well or higher plate assemblies that utilize a biodegradable polymer as […]
New platform to combine stem cell and CRISPR gene-editing technology with proven 3D cell culture techniques for producing standardized pancreatic islet disease models. Schlieren, Switzerland and Cambridge, UK – InSphero AG and DefiniGEN Ltd. today announced that they were awarded a €750K grant from Eurostars to develop a new drug-screening platform based on human pancreatic […]
TEMPE, Ariz.–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
